Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors
SAN DIEGO, July 30 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM ) today announced plans to develop a DNA-based orthobiologics product portfolio based on research and development by Cardium's Tissue Repair Company that will initially focus on non-union bone fractu...
United States FDA Clears the REGEN Trial to Test Bioheart's Combination Gene and Stem Cell Therapy in Heart Failure Patients
SUNRISE, Fla., July 28 /PRNewswire-FirstCall/ -- Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases announced today that the US FDA cleared a p...
Canadian researchers discover gene related to the appearance of aging
HALIFAX, July 15 /PRNewswire/ - Scientists in Atlantic Canada have found a gene
that may play a role in skin aging. Researchers were investigating the genetic cause of a rare disorder known as cutis laxa type 2 (CL2), which causes skin on the hands, feet and face to be loose and older looking, as ...
Novel gene found for dilated cardiomyopathy
Researchers in the Heart Institute at Cincinnati Children's Hospital Medical Center have discovered a novel gene
responsible for heart muscle disease and chronic heart failure in some children and adults with dilated cardiomyopathy (DCM).
Mutations in the ANKRD1 gene
may cause DCM, which is the...
deCODE Discovers a Gene Linked to Risk of Kidney Stones and Osteoporosis
REYKJAVIK, Iceland, June 29 /PRNewswire-FirstCall/ -- A discovery by
scientists at deCODE genetics (Nasdaq: DCGN ) and academic colleagues from
Iceland, the Netherlands and Denmark has pointed to a common biological
mechanism contributing to both kidney stones and decreased bone mineral
Syngenta Licenses Chromatin Gene Stacking Technology for Sugar Cane
RESEARCH TRIANGLE PARK, N.C., June 26 /PRNewswire/ -- Syngenta Biotechnology, Inc. announced today that it has entered into an exclusive worldwide research and commercial license agreement for Chromatin's proprietary gene
stacking technology in sugar cane.
Chromatin has developed a novel ap...
Scientists identify gene vital to early embryonic cells forming a normal heart and skull
New research from Cincinnati Children's Hospital Medical Center highlights the critical role a certain gene
and its protein play during early embryonic development on formation of a normal heart and skull.
In a study posted online June 15 by the Proceedings of the National Academy of Sciences ...
DNA2.0 Awarded US Patents for Breakthrough Gene Optimization Technology -- Company's Unique Algorithm Enables Expression Yields up to 50 Times Greater than Competing Approaches
The use of codon optimization in gene
synthesis has long been misunderstood. DNA2.0 has cracked the code on optimizing sequence design and has been awarded two US patents covering the technology. DNA2.0's approach goes beyond codon arrangement, so the company is introducing a new, more accurate c...
Monsanto, BASF Scientists Disclose Discovery of Gene Conferring Drought Tolerance in Corn Plants
Provides Yield Stability During Periods of Inadequate Water Supply
ST. LOUIS and LUDWIGSHAFEN, Germany, June 9, 2009 /PRNewswire-FirstCall/ -- Monsanto Company (NYSE: MON ) and BASF scientists unveiled the discovery that a naturally-occurring gene
can help corn plants comb...
Matrix Genomics, Elizabeth Corder, PhD - Gene Variation in the LRRK2 Gene and High Risk for Parkinson's Disease
Researchers at the National Institute on Aging, University College London, and Matrix Genomics, Inc. have identified a concise genetic signature found among a third of Parkinson's disease (PD) patients - but at very low frequency in the general population. The signature is found in the LRRK2 gene...
Sigma-Aldrich Honored With CIO 100 Award for Innovative Web Research Tool, Your Favorite Gene powered by Ingenuity
ST. LOUIS, June 4 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL ) announced today it has received CIO magazine's 2009 CIO 100 award for Your Favorite Gene
powered by Ingenuity ( http://www.sigma-aldrich.com/yfg ), a powerful web-based biological search tool that provides scientists...
Senesco Presents Pre-Clinical Multiple Myeloma Data at the 12th Annual Meeting of the American Society of Gene Therapy
NEW BRUNSWICK, N.J., May 27 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE Amex: SNT ) announced today that Richard Dondero, Vice President of Research and Development, will be presenting pre-clinical data from Senesco's multiple myeloma studies at...
ASCP Joins ACLU Lawsuit Opposing Gene Patents
The American Society for Clinical Pathology (ASCP) has joined the American Civil Liberties Union (ACLU) in a lawsuit challenging the legality of patents on human genes -- specifically, patents covering the BRCA1 and BRCA2 genes, which are associated with breast and ovarian cancer. The lawsuit wa...
Quark Pharmaceuticals Presented At ARVO Data Showing That PF-04523655 Enters Retinal Cells And Elicits Its Pharmacologic Effect Via Target Gene Knock-Down Without Activating TLR3
FREMONT, Calif., May 11 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced that Elena Feinstein, M.D., Ph.D., Chief Scientific Officer, presented a study titled, "PF-04...
GenomeQuest, Inc. Announces Digital Gene Expression Solution Within Its Sequence Data Management Platform
DigEx Solution offers completely interactive gene-level database to explore, understand, manage, and share next-generation sequencing DigEx runs.
WESTBOROUGH, Mass., May 5 /PRNewswire/ -- GenomeQuest, Inc., the leader in sequence data management, today announced that it has released a Digital...
Fat droplet nanoparticle delivers tumor suppressor gene to tumor and metastatic cells
Dr. Esther Chang describes the most recent developments in human trials of the first systemic, non-viral, tumor-targeted, nanoparticle method designed to restore normal gene
function to tumor cells while completely bypassing normal tissue April 21 at an American Association of Anatomists (AAA) sci...
Sigma-Aldrich Enters Exclusive Supply Agreement With Gene Oracle to Leverage Its Unique GeneIOS Gene Synthesis Platform
ST. LOUIS and MOUNTAIN VIEW, Calif., March 31 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL ) today announced an agreement to supply high quality services and oligonucleotides to Gene
Oracle, an innovative gene
synthesis company. Under the terms of the agreement, Sigma-Aldrich will be...
TauTaTis Discovers Potent Inhibitor of Parkinson's Disease Gene Activity
JACKSONVILLE, Fla., March 16 /PRNewswire/ -- TauTaTis, Inc. announces that its lead compound for inhibition of tau protein pathology, the specific neurodegenerative process in Alzheimer's Disease, has been recognized as the most potent inhibitor of the activity of the Parkinson's Disease gene
Discovery of a new retinal gene involved in childhood blindness
This release is available in French .
Montreal March 2nd, 2009 The team of Dr. Robert Koenekoop which includes Dr. Irma Lopez from the Research Institute of the MUHC at the Montreal Children's Hospital played a crucial role in the international collaboration that led to the discovery of ...
Anti-cancer gene discovered: Perspective for therapy
Starting with the tiny fruit fly, and then moving into mouse and human patients, researchers at VIB connected to the Center for Human Genetics (K.U. Leuven) showed that the same gene
suppresses cancer in all three. Reciprocally, switching off the gene
leads to cancer. The scientists think there is...
Sigma-Aldrich Launches Your Favorite Gene Powered by Ingenuity
Web Portal Provides Access to Dynamic Library of Life Science Research and Enables Experiment Modeling
ST. LOUIS, Jan. 27 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL ) and Ingenuity Systems today launched Your Favorite Gene
powered by Ingenuity, a Web-based biological search port...
New technique allows simultaneous tracking of gene expression and movement
Flies expressing green fluorescent protein (GFP) in their retina cells or other tissues can be tracked by specially modified video cameras, creating a real time computer record of movement and gene
expression. The new technique, described in the open access journal BMC Biotechnology , will allow ...
New and Updated Online Tutorials for Textpresso and Gene Ontology
Comprehensive tutorials on the Gene
Ontology and Textpresso databases enable researchers to quickly and effectively use these invaluable resources.
Seattle, WA (PRWEB) December 8, 2008 -- OpenHelix today announced the availability of an updated suite on the Gene
World Gene Amplification Technologies Market to Reach $2.2 Billion by 2015, According to New Report by Global Industry Analysts, Inc. Gene
Amplification technology is one of the rapidly growing markets in life science field. By the year 2015, global market for Gene
Amplification technologies is projected to reach $2.2 billion. Major factors that continue to affect the industry are patent expiry, and competitive advantages assoc...
World Gene Therapy Market to Reach $484 Million by 2015, According to New Report by Global Industry Analysts, Inc. Gene
therapy promises to be one of the most important frontiers in medicine. Although no significant achievements for curing disease have been achieved, the future seems to hold significant potential in terms of developing such approaches. By the year 2015, global market for gene
therapy is proje...
James L. Wittliff, Ph.D., FACB, to Present 'Predicting Breast Cancer Outcome with Gene Expression Signatures on the Ziplex(R) System' at the Association for Molecular Pathology Conference, October 30
Xceed Molecular will feature Ziplex automated gene-expression system at the conference, booth 519
WELLESLEY, Mass., Oct. 28 /PRNewswire/ -- Xceed Molecular, a pioneer in
the development of cost-effective, easy-to-use gene-expression analysis
systems, announced that renown...
Targeting Metastatic Cancer From the Inside: Epeius Biotech Reveals a New Generation of Tools for Medical Gene Delivery
SAN MARINO, Calif., Oct. 6 /PRNewswire/ -- Epeius Biotechnologies
Corporation today announced the publication of another landmark paper
describing recent technological advances in medical gene
latest scientific paper, entitled "Targeting metastatic cancer from the
inside: A new g...
Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award
MOUNTAIN VIEW, Calif., Aug. 26 /PRNewswire/ -- The 2008 European Gene
Expression Targeting Platform Technology Innovation Award is presented to
Israel-based Vascular Biogenics Ltd. for developing the Vascular Targeting
System (VTS(TM)). This unique platform has facilitated novel advancements
AMT Starts Collaboration With St. Jude Children's Research Hospital on Gene Therapy for Hemophilia B. Company Accesses Exclusive Commercial Rights to Final Therapy
AMSTERDAM, The Netherlands, July 15 /PRNewswire-FirstCall/ -- Amsterdam
Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene
therapy, today announced the start of a collaboration with St. Jude
Children's Research Hospital in Memphis, Tennessee, USA, on the development
AMT Makes Important Advance in the Development of its Gene Therapy for Hemophilia B -Company Accesses Technology to Prevent Immune Response
AMSTERDAM, The Netherlands, June 10 /PRNewswire-FirstCall/ -- Amsterdam
Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene
therapy, today announced that it obtained a license from 'TIGET' San
Raffaele Telethon Institute For Gene
Therapy, Italy, to use their micro-RNA
Amnis and Gene Company, Ltd. Announce Agreement to Market ImageStream Technology in China
SEATTLE, May 7 /PRNewswire/ -- Amnis Corporation and Gene
announced today the completion of an agreement under which Gene
will sell and service the Amnis ImageStream(R) system in China. Effective
immediately, the scientific research communities in Hong Kong, Shanghai,
ExonHit Launches Rat Genome SpliceArray(TM) Products to Expand High Resolution Gene Expression Profiling for use in Disease Modeling and Toxicogenomics
PARIS, May 6 /PRNewswire-FirstCall/ -- ExonHit Therapeutics S.A.
(Alternext: ALEHT), a drug and diagnostic discovery company, announces
today the availability of its new SpliceArray(TM) for use in disease
modeling and toxicogenomic applications by the basic and pre-clinical
Statement from Lighthouse International About the Study on Gene Therapy Concerning Leber's Congenital Amaurosis
NEW YORK, April 29 /PRNewswire/ -- Lighthouse International is a leader
in vision healthcare -- serving people who are visually impaired and
partially sighted for 103 years.
According to Dr. Tara A Cortes, President and CEO of Lighthouse
"This is a dramatic breakthrough in g...
Sloning and the Kornberg group at Stanford University starting evaluation project regarding the synthesis of a Statistically Randomized Gene Library
Munich, Germany, April 24, 2008 / b3c newswire / - Sloning BioTechnology and Roger Kornberg’s group at Stanford University are working on a project to synthesize a gene
mutant library where selected codons are introduced in a statistically expected and controlled ratio at preselected posi...
Oncolytics Biotech Inc. Announces Gene Therapy Publication on Reovirus Treatment for Melanoma
CALGARY, April 16 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.
("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that Prof. Alan
Melcher and his research group at St. James's University Hospital in Leeds,
U.K. published the results of their work in the April 10 online issue of
Sigma-Aldrich Partners With Sunset Molecular Discovery to Expand Your Favorite Gene Search Tool
Website Enables Researchers to Source Bioactive Small Molecules through Gene-based Search
ST. LOUIS, March 26 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq:
SIAL) today announced the addition of 1,300 bioactive small molecules to
its gene-based search tool, Your Fav...
Epeius Biotechnologies Awarded U.S. Patent for Targeted Injectable Gene Delivery In Vivo
SAN MARINO, Calif., March 25 /PRNewswire/ -- Epeius Biotechnologies
Corporation announced today the issue of U.S. Patent No. 7,347,998 for
Delivery in vivo. This patent provides additional
intellectual property protection for the platform of highly advanced
VIRxSYS Announces Interim Results from VRX496 Gene Therapy Phase II Trial
Disease Altering Treatment Shows Ability to Prevent HIV from Replicating
GAITHERSBURG, Md., Feb. 6 /PRNewswire/ -- VIRxSYS Corporation, a
privately held company developing gene
therapies for HIV and genetic
diseases, presented results from its Phase II trial of VRX496, a gene
therapy for the t...
deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women
REYKJAVIK, Iceland, Jan. 31 /PRNewswire-FirstCall/ -- Scientists from
deCODE genetics (Nasdaq: DCGN ) today report the discovery of two common,
single-letter variants in the sequence of the human genome (SNPs) that
regulate one of the principle motors of evolution. Versions of the two
Discovery of 'creator' gene for cerebral cortex points to potential stem cell treatments
Irvine, Calif. University of California, Irvine researchers have identified a gene
that is specifically responsible for generating the cerebral cortex, a finding that could lead to stem cell therapies to treat brain injuries and diseases such as stroke and Alzheimers.
Dr. Edwin Monuki, doctora...